Correlation between the Warburg effect and progression of triple-negative breast cancer

Shaojun Liu1, Yuxuan Li1, Meng Yuan1

  • 1Department of Oncology, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.

Frontiers in Oncology
|February 13, 2023
PubMed

Insights

Triple-negative breast cancer (TNBC) cells exhibit the Warburg effect, fueling their aggressive growth and resistance to chemotherapy. Targeting this metabolic shift shows promise, but metabolic plasticity in TNBC requires further research for effective treatments.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Molecular Biology

Background:

  • Triple-negative breast cancer (TNBC) lacks targeted therapies, making chemotherapy the primary treatment.
  • Chemoresistance and toxicity limit current TNBC treatment efficacy.
  • Metabolic reprogramming, particularly the Warburg effect, is a hallmark of cancer, promoting tumor aggressiveness.

Purpose of the Study:

  • To explore the role of the Warburg effect in TNBC progression.
  • To investigate the potential of targeting the Warburg effect for TNBC treatment.
  • To understand the impact of metabolic plasticity on therapeutic outcomes in TNBC.

Main Methods:

  • Review of existing literature on TNBC metabolism and therapeutic strategies.
  • Analysis of the Warburg effect's contribution to TNBC hallmarks like proliferation and metastasis.
  • Examination of metabolic plasticity as a mechanism for resistance to glycolysis inhibitors.

Main Results:

  • The Warburg effect is implicated in TNBC proliferation, metastasis, recurrence, immune escape, and multidrug resistance.
  • Targeting the Warburg effect demonstrates potential in inhibiting TNBC progression.
  • TNBC cells exhibit metabolic plasticity, allowing them to adapt to different pressures and evade targeted therapies.

Conclusions:

  • The Warburg effect is a critical driver of TNBC aggressiveness and therapeutic resistance.
  • Targeting metabolic reprogramming offers a potential therapeutic avenue for TNBC.
  • Metabolic plasticity presents a significant challenge that must be addressed to bridge the gap between Warburg effect-targeted therapies and clinical efficacy in TNBC.